Sabin's President of Global Immunization Dr. Bruce Gellin Testifies at House Briefing on Approval Processes for Safe, Effective COVID-19 Vaccine

Bruce Gellin, M.D., M.P.H., president of Global Immunization at the Sabin Vaccine Institute (Sabin) and former Deputy Assistant Secretary for Health and Director of the National Vaccine Program Office at the U.S. Department of Health and Human Services (HHS), testified on July, 14, 2020, at the House Subcommittee on Economic and Consumer Policy’s briefing entitled “Guardrails to Ensure a Safe and Effective COVID-19 Vaccine.”

Sabin Vaccine Institute Signs CHANGE Letter; Rejecting White House Decision to Pull Funding from WHO

WASHINGTON, D.C. — In response to the harmful and impulsive decision to withdraw funds from the World Health Organization (WHO), the Sabin Vaccine Institute (Sabin) joins the Center for Health and Gender Equity (CHANGE) and more than 65 other non-governmental organizations and global health institutions in an official letter of solidarity to WHO Director-General Dr. Tedros Adhanom Ghebreyesus and WHO staff worldwide.